Advanced search
Publication Cover
Epigenomics Volume 3, 2011 - Issue 4
Submit an article Journal homepage
551
Views
0
CrossRef citations to date
0
Altmetric
Review

Epigenetic Regulation of HIV-1 Transcription

Manoj Kumar Tripathy1 Department of Virology, University of Franche-Comté, EA4266, IFR133 INSERM, CHU Besançon, Besançon, France. Tel.:+33 381 218 877Fax+33 381 665 [email protected]View further author information
,
Wasim Abbas1 Department of Virology, University of Franche-Comté, EA4266, IFR133 INSERM, CHU Besançon, Besançon, France. Tel.:+33 381 218 877Fax+33 381 665 [email protected]View further author information
&
Georges Herbein1 Department of Virology, University of Franche-Comté, EA4266, IFR133 INSERM, CHU Besançon, Besançon, France. Tel.:+33 381 218 877Fax+33 381 665 [email protected]View further author information
Pages 487-502 | Published online: 18 Aug 2011

Bibliography

  • Miska EA , KarlssonC, LangleyE, NielsenSJ, PinesJ, KouzaridesT. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J.18 , 5099–5107 (1999).
  • Rayman JB , TakahashiY, IndjeianVBet al. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16 , 933–947 (2002).
  • Ng HH , BirdA. Histone deacetylases: silencers for hire. Trends Biochem. Sci.25 , 121–126 (2000).
  • Cress WD , SetoE. Histone deacetylases, transcriptional control, and cancer. J. Cell Physiol.184 , 1–16 (2000).
  • Mahlknecht U , WillJ, VarinA, HoelzerD, HerbeinG. Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression. J. Immunol.173 , 3979–3990 (2004).
  • Fuks F , BurgersWA, GodinN, KasaiM, KouzaridesT. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J.20 , 2536–2544 (2001).
  • Burgers WA , FuksF, KouzaridesT. DNA methyltransferases get connected to chromatin. Trends Genet.18 , 275–277 (2002).
  • Czermin B , SchottaG, HulsmannBBet al. Physical and functional association of SU(VAR)3–9 and HDAC1 in Drosophila. EMBO Rep. 2 , 915–919 (2001).
  • Tsai SC , ValkovN, YangWM, GumpJ, SullivanD, SetoE. Histone deacetylase interacts directly with DNA topoisomerase II. Nat. Genet.26 , 349–353 (2000).
  • Zhang X , WhartonW, YuanZ, TsaiSC, OlashawN, SetoE. Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. Mol. Cell. Biol.24 , 5106–5118 (2004).
  • Marzio G , WagenerC, GutierrezMI, CartwrightP, HelinK, GiaccaM. E2F family members are differentially regulated by reversible acetylation. J. Biol. Chem.275 , 10887–10892 (2000).
  • Braun H , KoopR, ErtmerA, NachtS, SuskeG. Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res.29 , 4994–5000 (2001).
  • Ammanamanchi S , FreemanJW, BrattainMG. Acetylated sp3 is a transcriptional activator. J. Biol. Chem.278 , 35775–35780 (2003).
  • Gu W , RoederRG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell90 , 595–606 (1997).
  • Boyes J , ByfieldP, NakataniY, OgryzkoV. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature396 , 594–598 (1998).
  • Imhof A , YangXJ, OgryzkoVV, NakataniY, WolffeAP, GeH. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol.7 , 689–692 (1997).
  • Ito A , KawaguchiY, LaiCHet al. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21 , 6236–6245 (2002).
  • Ito K , YamamuraS, Essilfie-QuayeSet al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J. Exp. Med. 203 , 7–13 (2006).
  • Gregoire S , XiaoL, NieJet al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell Biol. 27 , 1280–1295 (2007).
  • Hubbert C , GuardiolaA, ShaoRet al. HDAC6 is a microtubule-associated deacetylase. Nature 417 , 455–458 (2002).
  • Kovacs JJ , MurphyPJ, GaillardSet al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell. 18 , 601–607 (2005).
  • Roth SY , DenuJM, AllisCD. Histone acetyltransferases. Ann. Rev. Biochem.70 , 81–120 (2001).
  • Hodawadekar SC , MarmorsteinR. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Oncogene26 , 5528–5540 (2007).
  • Sterner DE , BergerSL. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev.64 , 435–459 (2000).
  • Allis CD , BergerSL, CoteJet al. New nomenclature for chromatin-modifying enzymes. Cell. 131 , 633–636 (2007).
  • Fu M , WangC, ZhangX, PestellRG. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem. Pharmacol.68 , 1199–1208 (2004).
  • Yang XJ , GregoireS. Metabolism, cytoskeleton and cellular signalling in the grip of protein Nε- and O-acetylation. EMBO Rep.8 , 556–562 (2007).
  • Baker SP , GrantPA. The SAGA continues: expanding the cellular role of a transcriptional co-activator complex. Oncogene26 , 5329–5340 (2007).
  • Nagy Z , ToraL. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene26 , 5341–5357 (2007).
  • Chan HM , La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell. Sci.114 , 2363–2373 (2001).
  • Liu X , WangL, ZhaoKet al. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451 , 846–850 (2008).
  • Martens JH , O‘SullivanRJ, BraunschweigUet al. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24 , 800–812 (2005).
  • Klose RJ , KallinEM, ZhangY. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet.7 , 715–727 (2006).
  • Shi Y . Histone lysine demethylases: emerging roles in development, physiology and disease. Nat. Rev. Genet.8 , 829–833 (2007).
  • Bannister AJ , ZegermanP, PartridgeJFet al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410 , 120–124 (2001).
  • Lachner M , O‘CarrollD, ReaS, MechtlerK, JenuweinT. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature410 , 116–120 (2001).
  • Martin C , ZhangY. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell. Biol.6 , 838–849 (2005).
  • Rea S , EisenhaberF, O‘CarrollDet al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406 , 593–599 (2000).
  • Jenuwein T . The epigenetic magic of histone lysine methylation. FEBS J.273 , 3121–3135 (2006).
  • Grewal SI , JiaS. Heterochromatin revisited. Nat. Rev. Genet.8 , 35–46 (2007).
  • Tachibana M , SugimotoK, NozakiMet al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16 , 1779–1791 (2002).
  • Tachibana M , UedaJ, FukudaMet al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 19 , 815–826 (2005).
  • Shi Y , LanF, MatsonCet al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 119 , 941–953 (2004).
  • Huang J , SenguptaR, EspejoABet al. p53 is regulated by the lysine demethylase LSD1. Nature 449 , 105–108 (2007).
  • Karytinos A , FornerisF, ProfumoAet al. A novel mammalian flavin-dependent histone demethylase. J. Biol. Chem. 284 , 17775–17782 (2009).
  • Shi YJ , MatsonC, LanF, IwaseS, BabaT, ShiY. Regulation of LSD1 histone demethylase activity by its associated factors. Mol. Cell.19 , 857–864 (2005).
  • Lee MG , WynderC, CoochN, ShiekhattarR. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature437 , 432–435 (2005).
  • Tsukada Y , FangJ, Erdjument-BromageHet al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439 , 811–816 (2006).
  • Falnes PO , JohansenRF, SeebergE. AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature419 , 178–182 (2002).
  • Trewick SC , HenshawTF, HausingerRP, LindahlT, SedgwickB. Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature419 , 174–178 (2002).
  • Dann CE 3rd, Bruick RK. Dioxygenases as O2-dependent regulators of the hypoxic response pathway. Biochem. Biophys. Res. Commun.338 , 639–647 (2005).
  • Tahiliani M , KohKP, ShenYet al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324 , 930–935 (2009).
  • Hoffart LM , BarrEW, GuyerRB, BollingerJM Jr, Krebs C. Direct spectroscopic detection of a C-H-cleaving high-spin Fe(IV) complex in a prolyl-4-hydroxylase. Proc. Natl Acad. Sci. USA103 , 14738–14743 (2006).
  • Ozer A , BruickRK. Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat. Chem. Biol.3 , 144–153 (2007).
  • Gao WY , CaraA, GalloRC, LoriF. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl Acad. Sci. USA90 , 8925–8928 (1993).
  • Malim MH . APOBEC proteins and intrinsic resistance to HIV-1 infection. Phil. Trans. R. Soc. Lond. B. Biol. Sci.364 , 675–687 (2009).
  • Goila-Gaur R , KhanMA, MiyagiE, StrebelK. Differential sensitivity of ‘old‘ versus ‘new‘ APOBEC3G to human immunodeficiency virus type 1 vif. J. Virol.83 , 1156–1160 (2009).
  • Chiu YL , SorosVB, KreisbergJF, StopakK, YonemotoW, GreeneWC. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+T cells. Nature435 , 108–114 (2005).
  • Goila-Gaur R , StrebelK. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology5 , 51 (2008).
  • Lin TY , EmermanM. Determinants of cyclophilin A-dependent TRIM5α restriction against HIV-1. Virology379 , 335–341 (2008).
  • Sebastian S , LubanJ. The retroviral restriction factor TRIM5α. Curr. Infect. Dis. Rep.9 , 167–173 (2007).
  • Towers GJ . The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology4 , 40 (2007).
  • Bukrinsky MI , StanwickTL, DempseyMP, StevensonM. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science254 , 423–427 (1991).
  • Williams SA , GreeneWC. Regulation of HIV-1 latency by T-cell activation. Cytokine39 , 63–74 (2007).
  • Zhou Y , ZhangH, SilicianoJD, SilicianoRF. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Virol.79 , 2199–2210 (2005).
  • Pierson TC , ZhouY, KiefferTL, RuffCT, BuckC, SilicianoRF. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol.76 , 8518–8531 (2002).
  • Lewinski MK , YamashitaM, EmermanMet al. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2 , e60 (2006).
  • Meehan AM , SaenzDT, MorrisonJHet al. LEDGF/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactors. PLoS Pathog. 5 , e1000522 (2009).
  • Schroder AR , ShinnP, ChenH, BerryC, EckerJR, BushmanF. HIV-1 integration in the human genome favors active genes and local hotspots. Cell110 , 521–529 (2002).
  • Lenasi T , ContrerasX, PeterlinBM. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell. Host Microbe4 , 123–133 (2008).
  • Verdin E . DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol.65 , 6790–6799 (1991).
  • Verdin E , ParasP Jr, Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J.12 , 3249–3259 (1993).
  • Van Lint C , EmilianiS, OttM, VerdinE. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J.15 , 1112–1120 (1996).
  • Yu W , WangY, ShawCA, QinXF, RiceAP. Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. Retrovirology3 , 32 (2006).
  • Liou LY , HerrmannCH, RiceAP. Human immunodeficiency virus type 1 infection induces cyclin t1 expression in macrophages. J. Virol.78 , 8114–8119 (2004).
  • Voinnet O . Induction and suppression of RNA silencing: insights from viral infections. Nat. Rev. Genet.6 , 206–220 (2005).
  • Huang J , WangF, ArgyrisEet al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13 , 1241–1247 (2007).
  • Ahluwalia JK , KhanSZ, SoniKet al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5 , 117 (2008).
  • Sung TL , RiceAP. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog.5 , e1000263 (2009).
  • Grewal SI , MoazedD. Heterochromatin and epigenetic control of gene expression. Science301 , 798–802 (2003).
  • Avram D , FieldsA, Pretty On Top K, Nevrivy DJ, Ishmael JE, Leid M. Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J. Biol. Chem.275 , 10315–10322 (2000).
  • Leid M , IshmaelJE, AvramD, ShepherdD, FraulobV, DolleP. CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. Gene Expr. Patterns4 , 733–739 (2004).
  • Arlotta P , MolyneauxBJ, ChenJ, InoueJ, KominamiR, MacklisJD. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron45 , 207–221 (2005).
  • Rohr O , LecestreD, Chasserot-GolazSet al. Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells. J. Virol. 77 , 5415–5427 (2003).
  • Marban C , RedelL, SuzanneSet al. COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells. Nucleic Acids Res. 33 , 2318–2331 (2005).
  • Marban C , SuzanneS, DequiedtFet al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J. 26 , 412–423 (2007).
  • Marcello A . Latency: the hidden HIV-1 challenge. Retrovirology3 , 7 (2006).
  • Maison C , AlmouzniG. HP1 and the dynamics of heterochromatin maintenance. Nat. Rev. Mol. Cell Biol.5 , 296–304 (2004).
  • Koiwa T , Hamano-UsamiA, IshidaTet al. 5´-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 76 , 9389–9397 (2002).
  • Taniguchi Y , NosakaK, YasunagaJet al. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2 , 64 (2005).
  • Kauder SE , BosqueA, LindqvistA, PlanellesV, VerdinE. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog.5 , e1000495 (2009).
  • Sune C , Garcia-BlancoMA. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol.69 , 6572–6576 (1995).
  • Perkins ND , EdwardsNL, DuckettCS, AgranoffAB, SchmidRM, NabelGJ. A cooperative interaction between NF-κ B and Sp1 is required for HIV-1 enhancer activation. EMBO J.12 , 3551–3558 (1993).
  • Williams SA , ChenLF, KwonH, Ruiz-JaraboCM, VerdinE, GreeneWC. NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J.25 , 139–149 (2006).
  • Gerritsen ME , WilliamsAJ, NeishAS, MooreS, ShiY, CollinsT. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl Acad. Sci. USA94 , 2927–2932 (1997).
  • Zhong H , MayMJ, JimiE, GhoshS. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell9 , 625–636 (2002).
  • Lusic M , MarcelloA, CeresetoA, GiaccaM. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J.22 , 6550–6561 (2003).
  • Thierry S , MarechalV, RosenzwajgMet al. Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-κB, and c-Jun to the long terminal repeat promoter. J. Virol. 78 , 12198–12206 (2004).
  • Calao M , BurnyA, QuivyV, DekoninckA, Van Lint C. A pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling code. Trends Biochem. Sci.33 , 339–349 (2008).
  • Kim YK , BourgeoisCF, PearsonRet al. Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J. 25 , 3596–3604 (2006).
  • Barboric M , NissenRM, KanazawaS, Jabrane-FerratN, PeterlinBM. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell8 , 327–337 (2001).
  • Garcia-Rodriguez C , RaoA. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J. Exp. Med.187 , 2031–2036 (1998).
  • He G , MargolisDM. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol. Cell. Biol.22 , 2965–2973 (2002).
  • Romerio F , GabrielMN, MargolisDM. Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF. J. Virol.71 , 9375–9382 (1997).
  • Imai K , OkamotoT. Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J. Biol. Chem.281 , 12495–12505 (2006).
  • Jiang G , EspesethA, HazudaDJ, MargolisDM. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol.81 , 10914–10923 (2007).
  • Sorin M , CanoJ, DasSet al. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication. PLoS Pathog. 5 , e1000463 (2009).
  • Lusic M , MarcelloA, CeresetoA, GiaccaM. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J.22 , 6550–6561 (2003).
  • Benkirane M , ChunRF, XiaoHet al. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273 , 24898–24905 (1998).
  • Ping YH , RanaTM. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem.276 , 12951–12958 (2001).
  • Yamaguchi Y , TakagiT, WadaTet al. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97 , 41–51 (1999).
  • Kao SY , CalmanAF, LuciwPA, PeterlinBM. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature330 , 489–493 (1987).
  • Coull JJ , RomerioF, SunJMet al. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 74 , 6790–6799 (2000).
  • Kiernan RE , VanhulleC, SchiltzLet al. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18 , 6106–6118 (1999).
  • Barboric M , PeterlinBM. A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation. PLoS Biol.3 , e76 (2005).
  • Parada CA , RoederRG. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature384 , 375–378 (1996).
  • Zhou M , HalanskiMA, RadonovichMFet al. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20 , 5077–5086 (2000).
  • Fujinaga K , IrwinD, HuangY, TaubeR, KurosuT, PeterlinBM. Dynamics of human immunodeficiency virus transcription. P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol.24 , 787–795 (2004).
  • Kaehlcke K , DorrA, Hetzer-EggerCet al. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol. Cell 12 , 167–176 (2003).
  • Bres V , KiernanR, EmilianiS, BenkiraneM. Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication. J. Biol. Chem.277 , 22215–22221 (2002).
  • Ott M , DorrA, Hetzer-EggerCet al. Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation. Novartis Found. Symp. 259 , 182–193; discussion 193–186, 223–185 (2004).
  • Mahmoudi T , ParraM, VriesRGet al. The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J. Biol. Chem. 281 , 19960–19968 (2006).
  • Pagans S , PedalA, NorthBJet al. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 3 , e41 (2005).
  • Zhang HS , WuMR. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. Virus Res.146 , 51–57 (2009).
  • Blazek D , PeterlinBM. Tat-SIRT1 tango. Mol. Cell29 , 539–540 (2008).
  • Kwon HS , BrentMM, GetachewRet al. Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell. Host Microbe 3 , 158–167 (2008).
  • Trono D , Van Lint C, Rouzioux C et al. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science329 , 174–180 (2010).
  • Rong L , PerelsonAS. Modeling HIV persistence, the latent reservoir, and viral blips. J. Theor. Biol.260 , 308–331 (2009).
  • Ylisastigui L , ArchinNM, LehrmanG, BoschRJ, MargolisDM. Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS18 , 1101–1108 (2004).
  • Quivy V , De Walque S, Van Lint C. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies. Subcell. Biochem.41 , 371–396 (2007).
  • Archin NM , EspesethA, ParkerD, CheemaM, HazudaD, MargolisDM. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retroviruses25 , 207–212 (2009).
  • Edelstein LC , Micheva-VitevaS, PhelanBD, DoughertyJP. Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS Res. Hum. Retroviruses25 , 883–887 (2009).
  • Contreras X , SchwenekerM, ChenCSet al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J. Biol. Chem. 284 , 6782–6789 (2009).
  • Ylisastigui L , CoullJJ, RuckerVCet al. Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors. J. Infect. Dis. 190 , 1429–1437 (2004).
  • Archin NM , KeedyKS, EspesethA, DangH, HazudaDJ, MargolisDM. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS23 , 1799–1806 (2009).
  • Keedy KS , ArchinNM, GatesAT, EspesethA, HazudaDJ, MargolisDM. A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J. Virol.83 , 4749–4756 (2009).
  • Korin YD , BrooksDG, BrownS, KorotzerA, ZackJA. Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol.76 , 8118–8123 (2002).
  • Brooks DG , HamerDH, ArlenPAet al. Molecular characterization, reactivation, and depletion of latent HIV. Immunity 19 , 413–423 (2003).
  • Reuse S , CalaoM, KabeyaKet al. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE 4 , e6093 (2009).
  • Zhang HS , ZhouY, WuMR, ZhouHS, XuF. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD+-dependent SIRT1 activity. Life Sci.85 , 484–489 (2009).
  • Greiner D , BonaldiT, EskelandR, RoemerE, ImhofA. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3–9. Nat. Chem. Biol.1 , 143–145 (2005).
  • Miranda TB , CortezCC, YooCBet al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 8 , 1579–1588 (2009).
  • Chang Y , ZhangX, HortonJRet al. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat. Struct. Mol. Biol. 16 , 312–317 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.